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Background: Mitral annulus calcification (MAC) is a progressive disease involving fibrosis and calcification that has been associated with 
significant cardiovascular morbidity. Limited data exists regarding risk factors for the progression of MAC in asymptomatic individuals without clinical 
cardiovascular disease.
Methods: The Multi-Ethnic Study of Atherosclerosis (MESA) is a longitudinal cohort study of subjects aged 45-84 years without evidence of 
clinical cardiovascular disease who underwent serial cardiac computed tomography studies with quantification of MAC using the Agatston method. 
Multivariable regression models were used to identify risk factors associated with the incidence and progression of MAC.
Results: At baseline, 534 of 5,895 (9%) subjects had prevalent MAC. Over a mean follow-up of 2.4 ± 0.9 years, 717 (12%) developed incident 
MAC. Age, male gender, white ethnicity, body mass index, diabetes, hypertension, low-density lipoprotein (LDL), current smoking and interleukin-6 
were significant predictors of incident MAC (Table). In subjects with prevalent MAC, the median rate of change was 15 [interquartile range: -16, 59] 
%/year. Only diabetes predicted the progression of prevalent MAC (Table).
Conclusion: Incident MAC was associated with several traditional cardiovascular risk factors in addition to white ethnicity, body mass index and 
interleukin-6. However, the progression of prevalent MAC was associated only with the presence of diabetes.
Table. Multivariable risk estimates for factors associated with incidence and progression of mitral annulus calcification.
Incident MAC Annual %-Change in MAC
OR (95% CI) p-valve `-coefficient (95% CI) p-valve
Age (per 10 yrs) 2.26 (1.89 - 2.70) <0.0001 0.37 (-0.19 - 0.94) 0.19
Male 0.72 (0.51 - 0.99) 0.04 0.12 (-0.73 - 0.99) 0.78
Race
White 1.84 (1.28 - 2.66) 0.001 0.64 (-0.29 - 1.59) 0.18
Chinese 1.22 (0.73 - 2.05) 0.45 0.12 (-1.52 - 1.77) 0.88
Hispanic referent (1.00) referent (1.00)
Black 0.75 (0.50 - 1.13) 0.16 0.08 (-1.07 - 1.23) 0.89
Body Mass Index (per 5 kg/m2) 1.16 (1.01 - 1.33) 0.04 -0.01 (-0.41 - 0.39) 0.96
Diabetes Mellitus 1.69 (1.20 - 2.38) 0.003 1.05 (0.10 - 2.00) 0.03
Hypertension 1.34 (1.08 - 1.65) 0.007 0.25 (-0.36 - 0.87) 0.42
No health insurance 1.03 (0.58 - 1.85) 0.92 0.43 (-1.47 - 2.32) 0.66
LDL-cholesterol (per 10 mg/dl) 1.07 (1.02 - 1.11) 0.004 -0.09 (-0.21 - 0.03) 0.14
HDL-cholesterol (per 10mg/dl) 1.05 (0.95 - 1.16 0.32 -0.07 (-0.35 - 0.21) 0.63
Smoking Status
Never referent (1.00) referent (1.00)
Former 1.22 (0.92 - 1.62) 0.17 0.43 (-0.36 - 1.22) 0.28
Current 1.60 (1.04 - 2.46) 0.03 0.1 (-1.37 - 1.57) 0.89
Statin use 1.25 (0.90 - 1.75) 0.18 -0.42 (-1.33 - 0.50) 0.37
Systolic BP (per 10 mmHg) 1.00 (0.92 - 1.09) 0.93 0.02 (-0.21 - 0.25) 0.86
Diastolic BP (per 10 mmHg) 1.03 (0.86 - 1.24) 0.72 -0.1 (-0.63 - 0.43) 0.71
eGFR (per 10 mL/min/1.73m2) 1.07 (0.99 - 1.16) 0.08 0.18 (-0.04 - 0.39) 0.1
Log (hs-CRP) 1.02 (0.89 - 1.17) 0.77 -0.16 (-0.56 - 0.25) 0.44
Log (IL-6) 1.57 (1.23 - 1.99) 0.0003 -0.11 (-0.81 - 0.59) 0.76
BP = blood pressure, eGFR = estimated glomerular filtration rate, HDL = high-density lipoprotein, hs-CRP = high-sensitivity C-reactive protein, IL = interleukin, LDL = low-density 
lipoprotein, MAC = mitral annulus calcification
